PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.
about
Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressureUse of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy.The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo.A double masked comparison of the intraocular pressure reducing effect of latanoprost 0.005% and 0.001% administered once daily in open angle glaucoma and ocular hypertension.Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.The placebo effect in early-phase glaucoma clinical trials.Intracellular calcium mobilization following prostaglandin receptor activation in human ciliary muscle cells.Latanoprost--a promising new glaucoma drug.Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
P2860
Q28368294-1B50E116-C27C-4EAE-8CFF-730393736A03Q31075828-72AECA11-786E-45C9-8615-8E13E32A5C42Q34511054-468D2EB7-E4E7-4F30-986B-3C683AEEE932Q35298399-0B9D5CAF-6DCC-4DC4-BA5F-79735EF147D3Q36856440-A8DF1759-5A37-47DD-923A-F999085F234CQ37309885-D5A5F8DE-62AB-4407-A623-E35912240C28Q38239431-BF0EEE0A-8E2E-4461-BEB0-2C5F787B433FQ39450869-895097EE-9D0E-4FEB-A376-CB97C1E13EFFQ39706170-0876991E-2A04-41C5-9389-F5F55371AAE5Q53559582-FF69A6D2-2A91-4DFB-937D-CB661950137E
P2860
PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@en
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@nl
type
label
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@en
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@nl
prefLabel
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@en
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@nl
P2860
P356
P1476
PhXA34--a prostaglandin F2 alp ...... ents with ocular hypertension.
@en
P2093
P2860
P304
P356
10.1136/BJO.76.4.214
P407
P577
1992-04-01T00:00:00Z